Flexsafe Pro Mixer Pre-Design Solution
Please check the Japanese version catalog for a significant increase in operability and stirring power!
A high-speed, flexible, and intelligent single-use mixer that accommodates all stirring processes in cGMP-compliant bioprocessing. In mixing processes within the bioprocess environment, quality and efficiency are critically important, and the choice of mixing equipment has a dramatic impact on both. A high-speed, flexible single-use mixer enhances manufacturers' competitiveness and improves productivity.
basic information
<Features> ▪ Providing unprecedented performance and quality assurance ▪ Control over the entire manufacturing process ▪ Quality assurance for fluid contact components ▪ Validation and quality assurance ▪ Guaranteeing the integrity of container closures ▪ Safe and reliable handling and shipping solutions from 5L to 500L ▪ Safe, self-expanding robust solutions
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Related Videos
catalog(11)
Download All CatalogsNews about this product(5)
-
Notice of Participation and Seminar Presentation at the 31st Annual Meeting of the Japan PDA Pharmaceutical Sciences Society
This event has ended. We will be exhibiting and presenting at the 31st Annual Meeting of the Japan PDA Pharmaceutical Science Society, which will be held at Tower Hall Funabori on December 5th and 6th, 2024. In the luncheon seminar, we will introduce quality assurance for single-use products regarding foreign substances and our efforts towards sustainability. At our exhibition booth, we will showcase single-use and filter products, as well as validation services. Please stop by. 【Event Overview】 Date: December 5th (Thursday) - 6th (Friday), 2024 Location: Tower Hall Funabori, 4-1-1 Funabori, Edogawa-ku, Tokyo 134-0091 *Pre-registration required 【Our Seminar】 Title: Efficiency of Single-Use Products and Quality Assurance of Flexsafe Bags (Leak, E|L, Management of Foreign Substances) Seminar Date and Time: December 5th (Thursday) 12:45-13:45
-
[Sending Recorded Video] Regarding the Final Filling Process in Compliance with the New EMA Annex 1 Guideline
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The revision of the EU GMP guidelines Annex 1 aims to deepen the relationship between Sartorius and our customers through mutual understanding of Quality Risk Management (QRM) and Contamination Control Strategy (CCS), while following its content. This time, we will particularly focus on the filling process and provide solutions using our products. [Seminar Overview] ▪ Date: February 8 (Thursday) at 15:00 (approximately 30 minutes) ▪ Method: Webinar recorded broadcast [Japanese, free of charge] *We kindly ask that participants refrain from joining with email addresses other than those from your own company or organization. Thank you for your understanding.
-
"We will send you a recorded video" Single-use system compliant with the new EMA Annex 1 Guideline.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. We will introduce the content of the revised EU GMP Guidelines Annex 1. While reviewing this content, we aim to deepen the relationship between Sartorius and our customers through mutual understanding, particularly regarding Quality Risk Management (QRM) and Contamination Control Strategy (CCS). Additionally, we will provide information on Sartorius's sterilization validation and the latest information on Extractables and Leachables (E|L), which we hope you will find useful. [Seminar Overview] ▪ Date: December 7 (Thursday) at 3:00 PM (approximately 30 minutes) ▪ Format: Webinar recorded broadcast [Japanese, Free] *We sincerely apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.
-
[End] Innovation Forum 2023 "Simplification of pDNA|mRNA Manufacturing Process by Sartorius"
This event has concluded. *Please note that there are currently no plans for on-demand distribution. mRNA pharmaceuticals are attracting attention as a new modality for drug discovery. Sartorius has a wide range of technologies that cover the mRNA manufacturing process, including E. coli culture, pDNA purification, IVT reactions, mRNA purification, and freeze storage. In this forum, we will provide a meaningful discussion platform centered around topics such as "pDNA|mRNA Manufacturing Processes," "Sartorius Manufacturing Platforms," and "Application Examples," inviting guest speakers to give presentations and facilitating questions and interactions from participants. Special Lecture Kazuhisa Uchida, Graduate School, Kobe University Capacity [In-person participation] 35 people *If there are many applications, a lottery will be held. [Online participation] 200 people *Please note that applications from competitors and research companies may be declined in advance.
-
We will send you a recorded video regarding the integrity of single-use bags.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Leaks are cited as one of the top three concerns regarding the use of single-use products. The rising cost of active pharmaceutical ingredients and the aspect of operational safety have also drawn attention to non-destructive testing before use. In this webinar, we will delve into Sartorius's concept of the integrity of single-use bags, focusing on pinhole size, water pressure, and intended use. 【Seminar Overview】 ▪ Date: February 2, 2023 (Thursday) from 3:00 PM (approximately 40 minutes) ▪ Method: Webinar recorded broadcast [Japanese, Free] If you are unable to participate on the day, please register first. We will send you the recorded video and a download URL for related product materials at a later date. *We apologize, but participation from other companies in the same industry and email addresses not associated with your organization is not permitted. Thank you for your understanding.